期刊文献+

靶向甘露糖受体的载体甘露糖化壳聚糖的全合成及其细胞毒性评价 被引量:4

Novel Mannosylated Chitosan to Target Mannose Receptors-Synthesis,and Its Characterization and Cytotoxicity
原文传递
导出
摘要 全合成甘露糖化壳聚糖,为靶向递送药物至巨噬细胞和树突状细胞提供载体材料。实验以甘露糖为起始原料,通过6步反应合成预期取代度为5%~10%的甘露糖化壳聚糖,分别用红外(FTIR)、元素分析等技术对其结构进行确证和表征,并通过HeLa和A549细胞毒性试验评价其细胞毒性。结果表明,所制备的甘露糖化壳聚糖为橘黄色固体,不溶于水,在pH低于6.0的醋酸盐缓冲液中溶解良好,取代度为7.35%;其细胞毒性较低,当浓度达到100μg/ml时,细胞存活率大于80%。合成的甘露糖化壳聚糖是一种安全的靶向递送载体。 In order to study the nanoparticle delivery system targeting macrophage and dendritic cells, Mannosylated chitosan (MC) with the expected degree of substitution to be 5%-10% was synthesized and characterized via FTIR and elemental ana!ysis. Cytotoxicity was evaluated in vitro via Hela cells and A549 cells MTT tests. It is found that the product is deep yellow solid with the degree of substitution to be 7.35%, insoluble in water while soluble well in acetic acid buffer (pH〈6.0), and the cyto- toxicity is low due to the fact that cell viability is higher than 80 % when the concentration of MC inereases to 100μg/ml. MC is successfully synthesized and safe to delivery of biological molecules.
出处 《药物生物技术》 CAS CSCD 2009年第3期207-211,共5页 Pharmaceutical Biotechnology
关键词 甘露糖化壳聚糖 合成 靶向 巨噬细胞和树突状细胞 细胞毒性 Mannosylated chitosan, Synthesis, Target, Macrophage and dendritic cells,Cytotoxicity
  • 相关文献

参考文献16

  • 1Wileman TE, Lennartz MR, Stahl PD, et al. Identification of the macrophage mannose receptor as a 175 - kDa membrane protein[J]. Proc Natl Acad Sci USA, 1986, 83 (8) :2501.
  • 2Stahl PD, Schulesinger PH, Singardson E, et al. Receptormediated pinoeytosis of mannose glycoconjugates by macrophages: characterization and evidence for receptor recycling [J]. Cell, 1980,19(1):207.
  • 3Sandra SD, Christian P, Matt C,et al. Mannose Receptor- Mediated Gene Delivery into Antigen Presenting Dendritic Cells [J]. Somatic Cell and Molecular Genetics, 2002, 27:65.
  • 4Lam JS, Mansour MK, Specht CA, et al. A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity[J]. J Immunol, 2005,175 (11) : 7496.
  • 5Jiang H L, Kang M L, Quan, J S, et al. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization [J]. Biornaterials, 2008,29 : 1931.
  • 6Ferkol T, Perales J C, Mularo F, et al. Receptor-mediated gene transfer into macrophage [J]. Proc Natl Acad Sci USA, 1996,93:101.
  • 7Kawakami S, Sato A, Nishikawa M, et al. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes [J]. Gene Therapy, 2000, 7:292.
  • 8Hirano S, Seino H, Akiyama Y, et al. Biocompatibility of chitosan by oral and intravenous administration [J]. Polym Mat Eng Sci, 1988,59:897.
  • 9KimTH, Hua J, HyunWK, etal. Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/cmice bearing CT-26 eardnoma ceils [J]. MolCancer Ther, 2006,5(7):1723.
  • 10Mayu H, Minoru M, Hiroyuki S, et al. Gene transfer by DNA/mannosylated ehitosan complexes into mouse peritoneal maerophages [J]. Biotechnol Lett, 2006,28(11) :815.

二级参考文献18

共引文献10

同被引文献53

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部